Tg Therapeutics TGTX
NASDAQ TGTX
$53.16 -0.04 (-0.08%)
At close: Oct 22, 2026 · 4:00 PM EDT

Tg Therapeutics (TGTX) Long-Term Debt Issuances (2019 - 2026)

Updated

Tg Therapeutics' Long-Term Debt Issuances was $747.66 million in Q1 2026.

Analysis

Tg Therapeutics (TGTX) Long-Term Debt Issuances (2019 - 2026) Analysis & Trends

For FY2024, Long-Term Debt Issuances at Tg Therapeutics came in at $244.82 million, up 879.3% from FY2023.

  • Long-Term Debt Issuances shows a five-year compound annual growth rate of 52.2% (FY2019 to FY2024).
  • In earlier years, Long-Term Debt Issuances was $25 million in FY2023 and $70 million in FY2021.
  • The Q1 2026 figure marks the lowest quarterly Long-Term Debt Issuances since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Tg Therapeutics 7.52 Bn 6.90 Bn 199.14 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 747.66 Mn
Sep 30, 2024 244.82 Mn
Mar 31, 2023 25.00 Mn
Dec 31, 2019 312,000.00
Sep 30, 2019 -4,000.00
Jun 30, 2019 -61,000.00
Mar 31, 2019 29.74 Mn
API Access

Tg Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=TGTX&period=max&api_key=YOUR_API_KEY